Skip to content

The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy With MultiPoint Pacing

The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy With MultiPoint Pacing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02782598
Enrollment
17
Registered
2016-05-25
Start date
2016-06-30
Completion date
2020-05-31
Last updated
2024-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Negative, Atrioventricular, Hysteresis, Cardiac Resynchronization, MultiPoint

Brief summary

The purpose of this study is to evaluate the application of Negative AV Hysteresis (NAVH) to improve electrical synchrony in MultiPoint Pacing (MPP) Cardiac Resynchronization Therapy (CRT) patients.

Interventions

DEVICECRT+NAVH

Cardiac Resynchronization Therapy with Negative Atrioventricular Hysteresis

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for implantation of an MPP-enabled SJM Quadripolar CRT Pacing System * QRS duration \> 140 ms * Left bundle branch block documented * Ability to provide informed consent for study participation * Willing to comply with the study evaluation requirements * At least 18 years of age

Exclusion criteria

* Resting ventricular rate \>100 bpm * Intrinsic PR interval \> 300 ms * Paroxysmal or persistent atrial tachycardia or atrial fibrillation documented * A recent myocardial infarction, ablation, drug intoxication, electrolyte imbalance, or any condition within the last 90 days that would be contraindicated for CRT programming changes in the opinion of the investigator * Women who are pregnant or who plan to become pregnant during the study

Design outcomes

Primary

MeasureTime frameDescription
Acute change in QRS duration due to CRT with NAVH, relative to intrinsic conduction1 dayAcute changes in surface ECG QRS duration resulting from Cardiac Resynchronization Therapy (CRT) with Negative Atrioventricular Hysteresis (NAVH) over a range of programmable values

Secondary

MeasureTime frameDescription
Acute changes in LV pressure-volume hemodynamics due to CRT with NAVH, relative to intrinsic conduction1 dayAcute changes in left ventricular pressure-volume hemodynamics resulting from Cardiac Resynchronization Therapy with Negative Atrioventricular Hysteresis over a range of programmable values
Change in QRS duration after one day of CRT with NAVH, relative to intrinsic conduction1 dayChanges in surface ECG QRS duration after one day of Cardiac Resynchronization Therapy with Negative Atrioventricular Hysteresis

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026